FDA stated in written correspondence for a START pilot program meeting that it is open to considering skin FXN concentration as a reasonably ...

Advancing a broad, potential best-in-class orexin receptor 2 (OX2R) agonist franchise with key data readouts expected in 2025ORX750 Phase 2a ...

In a resounding testament to its unwavering commitment to sustainability and operational excellence, Panchshil Realty proudly announces that EON Free Zone II, Kharadi - Panchshil Office Park has been ...